Last reviewed · How we verify

NCT05898659

Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Bimodal Fitting With or Without Synchronization

Recruiting now NA Last updated 14 January 2026
What this trial tests

NA trial testing ABFnoS then ABFS (Cochlear implant) in Sensorineural Hearing Loss, Bilateral in 20 participants. Currently enrolling.

Timeline
17 October 2023
Primary endpoint
15 December 2026
15 December 2026

Quick facts

Lead sponsorMED-EL Elektromedizinische Geräte GesmbH
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeother
Enrollment20
Start date17 October 2023
Primary completion15 December 2026
Estimated completion15 December 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

MED-EL Elektromedizinische Geräte GesmbH — full company profile →

Who can join

18 and older, any sex, with Sensorineural Hearing Loss, Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Main objective: For a bimodal fitting (hearing aid (HA) + cochlear implant (CI)): Comparison of a tonotopy based fitting strategy with synchronization between HA and CI (ABFS) to a tonotopy based fitting strategy without synchronization (ABFnoS) for the accuracy of sound localization. Secondary objectives: Comparison of ABFS to ABFnoS for the bias of sound localization. Comparison of ABFS to ABFnoS for speech perception in noise. Comparison of ABFS to ABFnoS for the auditory skills experienced by the subject.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sensorineural Hearing Loss, Bilateral

Currently open trials in the same condition.

Other MED-EL Elektromedizinische Geräte GesmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05898659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing